AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases - EurekAlert!
Insilico Medicine appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development – Oncology - EurekAlert!
Insilico Medicine showcases at WHX 2026: Connecting the Middle East with global partners to accelerate translational research - EurekAlert!
Insilico Medicine receives USD 5 million milestone payment from Menarini Group following First-in-Human (FIH) achievement for MEN2501 - EurekAlert!
Insilico Medicine and Qilu Pharmaceutical reach near $120 million drug development collaboration to accelerate novel cardiometabolic therapies - EurekAlert!
Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor - EurekAlert!
Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor for inflammatory bowel disease - EurekAlert!
Insilico Medicine integrates Nach01 Foundation Model with Microsoft Discovery to enable AI-native, enterprise-ready drug discovery workflows - EurekAlert!
Insilico Medicine announces US$888 million multi-year collaboration with Servier for drug discovery and development in oncology - EurekAlert! Science News Releases
Insilico Medicine lists on Hong Kong Stock Exchange, showing AI drug discovery momentum with 2025’s largest Hong Kong biotech IPO - EurekAlert!
Insilico Medicine and Taigen achieves license agreement to develop and commercialize AI-driven PHD inhibitor for anemia of Chronic Kidney Disease (CKD) - EurekAlert!
Insilico Medicine unveils winter edition of Pharma.AI, accelerating the path to pharmaceutical superintelligence - EurekAlert!
Insilico Medicine and Atossa Therapeutics publish AI-driven study in Nature's Scientific Reports identifying (Z)-endoxifen as a potential therapeutic candidate for glioblastoma - EurekAlert!
Join Insilico Medicine at NeurIPS 2025: Unveiling generative AI breakthroughs revolutionizing drug discovery and development - EurekAlert!
Meet us at PFF Summit 2025 | Insilico Medicine to showcase generative AI platform and introduce their latest AI-driven Pulmonary Fibrosis clinical research at PFF Summit 2025 in Chicago, IL - EurekAlert!
Insilico Medicine named a 2025 BostInno Fire Awards honoree - EurekAlert!
Insilico Medicine CEO Alex Zhavoronkov to speak on longevity and AI in healthcare at Fortune Global Forum in Riyadh - EurekAlert!
Showcasing gen-AI breakthroughs, Insilico Medicine presents fall edition of Pharma.AI quarterly launch - EurekAlert!
Insilico Medicine, Mabwell Bioscience, and ChemExpress forging ahead with ADC innovation through strategic collaboration - EurekAlert!
Towards pharmaceutical super intelligence: During BioHK 2025, Insilico Medicine gathers industry leaders to shape the future of AI in healthcare - EurekAlert!
